Semax, a synthetic peptide derived from the adrenocorticotropic hormone (ACTH) fragment ACTH(4-10), has been shown to significantly impact the expression of various neurotrophic factors in the brain. Its primary effects include elevating the expression of Brain-Derived Neurotrophic Factor (BDNF) and its receptor TrkB, promoting neuroprotection and neurogenesis, counteracting neurotoxic effects and neurodegeneration, influencing gene expression related to the vascular system, modulating immune response genes, and contributing to mitochondrial stability [1].
What the AI assistants say
AI assistants collectively agree that Semax has a significant impact on neurotrophic factors, particularly BDNF, in the brain. They highlight that Semax robustly upregulates multiple neurotrophic factors, with effects seen within hours of administration. The AI assistants also agree on the mechanisms by which Semax achieves these effects, including binding to melanocortin receptors, activation of intracellular signaling pathways such as the MAPK/ERK and PI3K/Akt pathways, and direct gene transcription modulation. Additionally, they note that Semax has neuroprotective and anti-inflammatory effects and can modulate dopaminergic signaling. The AI assistants differ in the level of detail they provide on these mechanisms and the specific studies that support these claims, but they generally concur on the overall effects of Semax on neurotrophic factors.
What the research actually shows
The research supports the AI assistants’ consensus by demonstrating Semax’s impact on neurotrophic factors through multiple mechanisms. Semax elevates the expression of BDNF and the TrkB receptor, which are crucial for neuronal survival, growth, and differentiation [1]. It promotes neuroprotection and neurogenesis, counteracts the inhibition of learning and memory induced by heavy metals, and inhibits neurodegeneration caused by dopamine oxidation [1]. Semax also influences gene expression related to the vascular system, which is essential for neuronal health and the supply of nutrients to the brain [1]. Furthermore, Semax modulates immune response genes during ischemic brain injury in rats [3], which can impact the expression and function of neurotrophic factors. Lastly, Semax contributes to mitochondrial stability under stress, which is particularly important as mitochondrial dysfunction has been implicated in neurodegenerative diseases, and neurotrophic factors play a role in maintaining mitochondrial health [1].
While the AI assistants and the research generally align in their assessment of Semax’s impact on neurotrophic factors, the research provides a more comprehensive view by including additional mechanisms such as the influence on vascular system genes and mitochondrial stability. The research also emphasizes the potential therapeutic implications of Semax for conditions associated with neurodegeneration and cognitive impairment.
Bottom line:
Semax significantly influences the expression of neurotrophic factors in the brain, promoting neuronal health and protecting against neurodegeneration.
References
- Boundless Upgrade Your Brain, Optimize Your Body and Defy — Ben Greenfield
- Cellular Transplantation_ From Lab to Clinic
- Gene Therapy in Ophthalmology
- Handbook of Biologically Active Peptides
- In Situ Hybridization Techniques for the Brain
- Neuroprotective Effects of Tripeptides—Epigenetic Regulators — Khavinson, Vladimir (author)
- Peptide Protocols Volume One — William A Seeds MD
- Selenium_ Its Molecular Biology and Role in Human Health
- Stem Cell Biology and Gene Therapy
Continue your research
Part of our Semax: Brain & Nervous System guide.
- What are the effects of Semax on the dopaminergic system?
- How does Semax affect synaptic plasticity and neurotransmission?
- How does Semax affect the levels of neurotransmitters in the brain?
Related topics:
- What role does Semax play in promoting recovery from traumatic brain injury?
- How does the duration of Semax treatment impact its therapeutic effects?
- How does Semax influence the expression of genes related to neuroprotection?